Low tumour expression is associated with better survival in neuroblastoma patients, and incidentally, upon ATRA treatment, we found BEGAIN expression is downregulated in differentiating cell lines but not in SH-EP, where it is upregulated (Figure 5C–E right panel). This evidence concerns the gene BEGAIN and neuroblastoma.